Concepedia

Katherine J Cato

KJ

2

Publications

79

Citations

2

H-Index

2006

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Katherine J Cato is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacotherapy, psychopharmacology, and drug discovery.

Top concepts

MedicinePsychiatryPharmacologySchizophreniaDrug DiscoveryPharmacotherapyPsychopharmacologyAddictionImmunologyNeuroscience

Publications per year

2006–2007

2

Publications

2

In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia

Lee A. Dawson, Katherine J Cato, Claire M. Scott et al. · Neuropsychopharmacology · 2007 · 43 citations · Full text

Psychiatry, Medicine, Immunology +9

Pharmacological Profile of Antipsychotics at Monoamine Receptors: Atypicality Beyond 5-HT2A Receptor Blockade

Martyn Wood, Claire M. Scott, Kirsten L. Clarke et al. · CNS & Neurological Disorders - Drug Targets · 2006 · 36 citations

Newer Atypical Apd, Neuropsychology, Monoamine Receptors +17

Rows per page

1–2 of 2